FutureGen Industries Provides Investment Performance Update and Shares Realized Gains

Executive Summary

• FutureGen Industries reported realized gains of $1,250,792.09 from the sale of shares in three portfolio companies (Onco‑Innovations, ASEP Medical Holdings, and Core One Labs) during 2025.
• The company highlighted its disciplined investment approach and disclosed specific transaction details for each investment, including purchase prices, share counts, proceeds, and gains.
• Management reaffirmed commitment to creating sustainable shareholder value through continued capital deployment.

Key Details

• Onco‑Innovations Investment – Invested $31,175 in June 2025; sold 500,000 shares in 2025 for a realized gain of $765,065.33.
• ASEP Medical Holdings Investment – Acquired 500,000 Safecoat shares (Nov 14 2022) at $0.0231 per share; received 461,400 ASEP shares at a deemed value of $0.20 per share; sold 346,050 ASEP shares in 2025 for a realized gain of $118,255.57.
• Core One Labs Investment – Invested $200,000 on Dec 8 2022 (16,186 shares at $12.36 each); conversion to 527,961 COOL shares at $0.38 per share plus 131,990 bonus shares; sold 652,579 COOL shares in 2025 for proceeds of $348,068.19 and a realized gain of $167,473.19.
• Total realized gains across all three investments: $1,250,792.09.
• CEO Kristian Thorlund stated the gains reflect “the thoughtful approach we take in selecting opportunities and supporting companies pursuing meaningful advancements.”

Notable Quotes

"We are pleased with the realized gains generated through our portfolio activities. These outcomes reflect the thoughtful approach we take in selecting opportunities and supporting companies pursuing meaningful advancements." – Kristian Thorlund, CEO